CD8A and type 1 diabetes mellitus: Recent evidence further showed that the ‘alternative splicing signature’ is also seen in the immunopeptidome of HLA-A2 and HLA-A3 restricted epitopes, leading to the generation of islet-reactive CD8+ T-cells both in T1D patients and healthy subjects (21, 25).